[Zanubrutinib - Relapsed or refractory follicular lymphoma]

Bull Cancer. 2024 Jun;111(6):542-544. doi: 10.1016/j.bulcan.2024.02.009. Epub 2024 Apr 5.
[Article in French]
No abstract available

Keywords: BTK inhibitors; Follicular lymphoma; Inhibiteurs de BTK; Lymphome folliculaire; Lymphoproliferative disease; Syndromes lymphoprolifératifs; Zanubrutinib.

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Drug Resistance, Neoplasm
  • Humans
  • Lymphoma, Follicular* / drug therapy
  • Neoplasm Recurrence, Local / drug therapy
  • Piperidines* / therapeutic use
  • Protein Kinase Inhibitors / adverse effects
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles* / adverse effects
  • Pyrazoles* / therapeutic use
  • Pyrimidines* / therapeutic use

Substances

  • Pyrimidines
  • zanubrutinib
  • Pyrazoles
  • Antineoplastic Agents
  • Piperidines
  • Protein Kinase Inhibitors